We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




High Dose Delivery and Prone Breast Treatment Capabilities Added to Advanced Radiotherapy Cancer Treatment

By MedImaging International staff writers
Posted on 29 Dec 2011
Updated control software enables high-intensity dose radiotherapy and better support for treating breast cancer in the prone position.

Clinac and Trilogy medical linear accelerators from Varian Medical Systems (Palo Alto, CA, USA) are used to treat cancer with targeted radiotherapy, have been updated to provide higher doses up to two times faster than was previously possible. They can now also better facilitate treating breast cancer patients on their stomachs (in the prone position) instead of their backs--an approach that can reduce the volume of lung and heart tissue exposed to radiation during treatment.

Updated control software, which received 510(k) clearance in November from the US Food and Drug Administration (FDA), adds a high intensity mode to the Clinac and Trilogy machines, enabling dose delivery rates of up to 2,400 monitor units per minute--double their former highest output.

“Our high intensity mode makes it possible to deliver some treatments up to 50% faster than is possible without it,” said Chris Toth, senior director of marketing for Varian’s oncology systems business. “We’re seeing trends toward the use of hypofractionation and radiosurgical approaches for many types of cancer, which means that higher doses are delivered in just one or a few treatment sessions for quick ablation of a tumor. There has been encouraging research supporting this approach for the treatment of cancers of the brain, spine, and lung, as well as for prostate cancer. With high intensity mode, our Clinac and Trilogy machines can deliver these high dose treatments within a clinically-feasible timeframe.”

Varian also received FDA clearance for the Pivotal Care solution for prone breast treatment, an innovation that allows patients to be treated on their stomachs rather than their backs. Recent studies have shown that, for many women without axillary lymph node disease, treatment in the prone position can be used to reduce significantly the volume of lung and heart tissue exposed to the treatment beam.

“When a woman is in the prone position for treatment, the targeted breast falls away from the rest of her body, creating a greater separation between the breast and the critical organs that lie behind her chest wall,” Mr. Toth stated. “The Pivotal solution makes it possible to treat an anatomical area that lies below the couch top, such as a breast that is hanging away from the rest of the body, enabling physicians to choose this approach if it is best for a particular patient. Varian is committed to providing clinicians with tools that make it faster and easier to offer cancer patients advanced treatments that have the best likelihood of a positive outcome.”

Related Links:

Varian Medical Systems



Multi-Use Ultrasound Table
Clinton
Half Apron
Demi
Pocket Fetal Doppler
CONTEC10C/CL
X-ray Diagnostic System
FDX Visionary-A

Channels

General/Advanced Imaging

view channel
Image: Example snapshots of the photon energy density at t = 0.5, 0.7, 0.9, 1.1 nanoseconds (ns) on the y = 2.0 cm plane (Horie, S., Yajima, H., Abe, M. et al., Biomedical Engineering Letters (2026). DOI: 10.1007/s13534-026-00578-9)

AI Tool Enables Real-Time Diffuse Optical Tomography for Brain Lesion Detection

Diffuse optical tomography is a noninvasive imaging technique that uses near-infrared light to detect internal abnormalities such as cerebral hemorrhage and tumors. Its clinical utility for real-time ... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.